Patents Assigned to Neurotrope Bioscience
  • METHODS AND COMPOSITIONS FOR TREATMENT OF ALZHEIMER'S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS
    Publication number: 20200323817
    Abstract: A method for treating Alzheimer's disease (AD) by administering to an AD patient a PKC activator, such as a bryostatin-1, without administering a NMDA receptor antagonist, such as memantine.
    Type: Application
    Filed: June 28, 2020
    Publication date: October 15, 2020
    Applicant: NEUROTROPE BIOSCIENCE, INC.
    Inventor: Daniel L. Alkon
  • Methods and compositions for treatment of lipid storage disorders
    Patent number: 9724328
    Abstract: Treating subjects having a lipid storage disorder with a composition comprising a PKC activator, such as bryostatins, bryologs, and polyunsaturated fatty acids.
    Type: Grant
    Filed: April 14, 2015
    Date of Patent: August 8, 2017
    Assignees: Icahn School of Medicine at Mount Sinai, Neurotrope Bioscience
    Inventors: Yiannis A. Ioannou, Lawrence Altstiel, David R. Crockford, Sathapana Kongsamut